Selank Dosage Guide: Intranasal and SubQ Protocols for Anxiety and Cognition

Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics in Russia, where it was registered as a pharmaceutical drug for generalized anxiety disorder and neurasthenia. It is a stabilized analog of the endogenous tetrapeptide tuftsin, extended with additional amino acids to improve bioavailability and duration of action.

Unlike benzodiazepines and other anxiolytics that primarily suppress the central nervous system, Selank appears to work through GABA modulation, enkephalin regulation, and BDNF (brain-derived neurotrophic factor) upregulation — producing anxiety relief without sedation, dependence, or the cognitive blunting associated with conventional anxiolytics.

This guide covers the evidence-based dosing protocols for both intranasal and subcutaneous routes, cycling recommendations, and the distinct anxiety and cognitive applications.

How Selank Works

Selank's mechanism is multifaceted and not fully characterized, but several pathways are established:

GABA modulation: Selank enhances GABAergic tone without directly binding GABA-A receptors in the way benzodiazepines do. This appears to account for its anxiolytic effects while explaining the absence of typical benzo side effects (sedation, cognitive impairment, physical dependence).

Enkephalin regulation: Selank slows the enzymatic breakdown of met-enkephalin and leu-enkephalin, endogenous opioid peptides that play a role in stress modulation and emotional regulation.

BDNF upregulation: In animal and preliminary human studies, Selank increases hippocampal BDNF levels. BDNF supports neuronal survival, synaptic plasticity, and cognitive function. This mechanism partially explains Selank's nootropic properties.

Serotonin metabolism: Research indicates Selank modulates serotonin turnover in a balanced way — not simply increasing serotonin levels (as SSRIs do) but normalizing serotonin metabolism in stress states.

Administration Routes

Selank is effective via two primary routes:

Intranasal Administration

The most commonly used route. Intranasal delivery bypasses the blood-brain barrier to a meaningful degree, with peptides absorbed directly through the nasal mucosa and transported to the brain via the olfactory pathway. This explains why intranasal Selank produces faster central effects (anxiety relief within 20–40 minutes) compared to subcutaneous injection.

Intranasal Selank requires a nasal atomizer or spray bottle calibrated to deliver precise volumes. Most preparations are formulated at 0.15% concentration (1500 mcg/mL), so standard drops or sprays can be measured with this in mind.

Subcutaneous Injection

Produces systemic effects with slightly delayed central onset compared to intranasal but provides more consistent bioavailability and is better suited to users who track IGF-1, BDNF, or other markers. SubQ injection is also useful when nasal congestion might impair absorption.

Dosage Protocols

Standard Anxiety and Mood Protocol

• Dose: 250–500 mcg per administration
• Route: Intranasal (2–3 drops per nostril with typical 0.15% preparations)
• Frequency: Once to twice daily
• Timing: Morning, and optionally mid-afternoon during high-stress periods
• Cycle: 14 days on, 14 days off (see Cycling section)

Cognitive Enhancement / Nootropic Protocol

• Dose: 250 mcg per administration
• Route: Intranasal or subQ
• Frequency: Once daily, mornings
• Cycle: 10–14 days on, 10–14 days off
• Stacking: Often combined with Semax (morning Semax, afternoon Selank) for complementary nootropic effects

SubQ Protocol

• Dose: 250–500 mcg
• Frequency: Once or twice daily
• Injection site: Abdominal subcutaneous fat
• Volume: Typically 0.5–1 mL depending on peptide concentration

The 14-Day Cycle Protocol

The 14-day on / 14-day off cycle is the most widely used structure for Selank. This protocol originates from Russian clinical research, where 14-day courses were used in registered clinical trials for anxiety and neurasthenia. Key rationale:

• Selank appears to produce lasting anxiolytic and neuroplastic effects that persist after the cycle ends, making continuous daily use unnecessary
• BDNF increases induced by Selank may take 7–14 days to reach their full neuroplastic effect
• The off-period allows the body to integrate the changes from the active cycle; many users report the subjective benefits of Selank actually peak in the first week off-cycle

Longer cycles (up to 30 days) are reported anecdotally without apparent dependence or withdrawal, but the 14-day model aligns best with existing research.

Selank for Anxiety: What to Expect

Selank's anxiolytic profile is distinct from both SSRIs and benzodiazepines:

• Onset: Intranasal effects are felt within 20–60 minutes; subQ effects within 1–2 hours
• Character: Anxiety reduction without sedation or cognitive dulling; users typically describe a "quiet mind" without the emotional blunting of SSRIs
• Acute vs. cumulative: Selank produces both acute (same-day) anxiolytic effects and cumulative effects that build over a 10–14 day course
• Stress resilience: Repeated courses appear to improve baseline stress tolerance even during off-cycle periods, consistent with the BDNF/neuroplasticity mechanism

For generalized anxiety disorder, social anxiety, and situational anxiety (public speaking, high-stakes performance), Selank is commonly used both as a course treatment and as an acute dose taken 30–60 minutes before a stressful event.

Selank's Nootropic Applications

In addition to anxiety, Selank is used for:

Memory and learning: Animal studies show improved performance in maze-learning tasks, memory consolidation, and recall. Human anecdotal reports consistently describe enhanced working memory and verbal fluency during Selank courses.

Focus without stimulation: Unlike racetams or amphetamine-class stimulants, Selank improves attention and processing speed through anxiolytic rather than stimulatory mechanisms. This makes it suitable for people who cannot tolerate stimulants.

Sleep quality: Some users report improved sleep quality on Selank, particularly a reduction in anxiety-driven insomnia. The mechanism may involve normalization of overnight cortisol and serotonin metabolism.

Combining Semax and Selank: A well-known protocol in Russian nootropic communities involves using Semax in the morning (for cognitive activation) and Selank in the evening or afternoon (for anxiety management and BDNF support). These two peptides complement each other's mechanisms. See the Semax dosage guide for the Semax side of this protocol.

Side Effects and Safety Profile

Selank has an excellent safety record in both animal research and registered human clinical use in Russia. Reported side effects are rare and typically mild:

• Fatigue or sedation: Uncommon at standard doses; more frequent at the higher end (500 mcg) in sedation-sensitive individuals
• Nasal irritation: With intranasal use; the peptide solution pH may cause mild irritation in some users, especially with frequent use
• Appetite changes: Minor, transient changes in appetite have been reported by some users
• Emotional blunting: Rare, but occasionally reported at higher doses or with very frequent use

No physical dependence, rebound anxiety, or withdrawal syndrome has been documented with Selank in clinical research, which represents a significant safety advantage over conventional anxiolytics.

Selank vs. Semax: Choosing the Right Peptide

Selank and Semax are Russia's two flagship nootropic peptides and are often compared:

| Property | Selank | Semax | |----------|--------|-------| | Primary effect | Anxiolytic, calming | Activating, cognitive focus | | BDNF | Moderate increase | Strong increase | | Anxiety | Reduces | Neutral to mild reduction | | Energy | Neutral | Mild increase | | Best for | Anxiety + cognition | Focus + memory |

Frequently Asked Questions

Q: What concentration of Selank nasal spray should I use? The most common preparation is 0.15% (1,500 mcg/mL). At this concentration, a standard nasal atomizer spray delivers approximately 100 mcg per actuation. Two to three actuations per nostril achieves a 250–500 mcg dose.

Q: How quickly does Selank work for anxiety? Intranasal Selank typically produces noticeable anxiolytic effects within 20–40 minutes. SubQ injection effects take slightly longer. The acute dose is effective for situational anxiety (e.g., before a presentation or stressful event).

Q: Can Selank be used long-term without cycling? No long-term dependence or tolerance has been documented in clinical research. However, most practitioners recommend cycling (14 on / 14 off) based on the original Russian clinical protocols and the observation that the anxiolytic benefits seem to consolidate during off periods.

Q: Is Selank better than SSRIs for anxiety? They work differently and cannot be directly compared. Selank has a faster onset, fewer side effects, and no withdrawal syndrome. SSRIs have decades of clinical trial data and are FDA-approved. Selank is not a replacement for prescribed medication without medical guidance.

Q: Can Selank and Semax be taken together? Yes, and this combination is widely used. A common approach is intranasal Semax in the morning and intranasal Selank in the afternoon or evening, taking advantage of their complementary effects on cognitive activation and anxiety reduction.

Q: Does Selank require refrigeration? Lyophilized Selank powder is stable at room temperature for extended periods. Once reconstituted in bacteriostatic water, store refrigerated and use within 4–6 weeks. Nasal spray preparations should be kept refrigerated.